Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. [electronic resource]
Producer: 20120530Description: 1090-6 p. digitalISSN:- 1791-2431
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Blotting, Western
- Carcinoma, Hepatocellular -- enzymology
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Dose-Response Relationship, Drug
- Down-Regulation
- Enzyme Activation
- Enzyme Activators -- pharmacology
- Flavanones -- pharmacology
- Flow Cytometry
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Hep G2 Cells
- Humans
- Liver Neoplasms -- enzymology
- MAP Kinase Kinase 7 -- antagonists & inhibitors
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- RNA Interference
- RNA, Messenger -- metabolism
- Rats
- Resting Phase, Cell Cycle -- drug effects
- Reverse Transcriptase Polymerase Chain Reaction
- Time Factors
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.